Cargando…
An Overview of the Development of New Vaccines for Tuberculosis
Currently, there is only one licensed vaccine against tuberculosis (TB), the Bacillus Calmette–Guérin (BCG). Despite its protective efficacy against TB in children, BCG has failed to protect adults against pulmonary TB, lacks therapeutic value, and causes complications in immunocompromised individua...
Autores principales: | Whitlow, E., Mustafa, A. S., Hanif, S. N. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712106/ https://www.ncbi.nlm.nih.gov/pubmed/33027958 http://dx.doi.org/10.3390/vaccines8040586 |
Ejemplares similares
-
Therapeutic Vaccines for Tuberculosis: An Overview
por: Bouzeyen, Rania, et al.
Publicado: (2022) -
Immunoinformatics and Vaccine Development: An Overview
por: Oli, Angus Nnamdi, et al.
Publicado: (2020) -
Development of New Preventive and Therapeutic Vaccines for Tuberculosis
por: Kwon, Bo-Eun, et al.
Publicado: (2018) -
Research and development of new tuberculosis vaccines: a review
por: Schrager, Lewis K., et al.
Publicado: (2019) -
Developing New Anti-Tuberculosis Vaccines: Focus on Adjuvants
por: Franco, Ana Rita, et al.
Publicado: (2021)